Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Eli Lilly’s updated fair value estimate has shifted from US$1,297.31 to US$1,325.39, adding a fresh data point to an already ...

Berenberg upgrades Eli Lilly to Buy with a $1,400 target, citing GLP-1 demand, Foundayo catalysts, and M&A pipeline. Read ...

The big story today with Eli Lilly is its hugely successful GLP-1 drugs, but the long-term story is likely to be about its ...

The drugmaker has a lot riding on continued clinical progress.

As Eli Lilly And Co LLY prepares to report third-quarter results in late October, Guggenheim analyst Seamus Fernandez ...

The last few months have not been a particularly pleasant time for shareholders of pharmaceutical giant Eli Lilly and Company (LLY). Since I last reaffirmed the company as a ‘hold’ candidate back in ...

Eli Lilly stakes its trillion-dollar valuation on mid-stage data for a two-drug obesity combo, and the September 30 readout will reveal whether eloraTZP is a genuine franchise leap or an expensive ...

The company logo etched in stone is seen at the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Lilly, a pharmaceutical company, employs more than 12.000 ...

In 1876, Colonel Eli Lilly opened a small pharmaceutical company in Indianapolis with an idea that was, at the time, radical to some: make medicine that actually worked. He had witnessed soldiers die ...

Turn on, tune in, drop out: Christian Angermayer has cemented his place in psychedelics by selling biotech AtaiBeckley to Eli Lilly in the biggest acquisition in the industry. "The future is ...